Prostate News and Research

RSS

Scientists identify on/off obesity-induced switch to slow cancer progression

Having established that excessive fat tissue can fuel the growth of certain cancers, researchers have turned their attention to the molecular mechanisms involved in the process in the hopes of developing new cancer treatments.

21 Jun 2016

Fetal BPA exposure leads to harmful change in adult uterine response to estrogens

Low levels of BPA exposure may be considered safe, but new research published online in The FASEB Journal, suggests otherwise. In the report, researchers from Yale show that the genome is permanently altered in the uterus of mice that had been exposed to BPA during their fetal development.

17 Jun 2016

Nut consumption may lower risk of overall mortality in prostate cancer patients

In a large prospective study published online in the British Journal of Cancer, researchers looked at the association between nut consumption and prostate cancer risk and mortality among 47,299 men in the Health Professionals Follow-up Study.

15 Jun 2016

MUTAs and GTAs act as medical model to train students

Every profession has a basic skill it seems they should just know. Architects can draw a blueprint, lawyers can write a brief and physicians and nurses can perform a physical exam.

15 Jun 2016

Prkci gene plays role in organizing cells during early embryo, organ formation

A gene called Prkci can point cells in the right direction, according to a new study in Developmental Biology.

14 Jun 2016

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

Prostate cancer screening with prostate-specific antigen (PSA) has been shown to reduce death and the spread of prostate cancer to other parts of the body, but the PSA test remains highly controversial as it frequently leads to over diagnosis and over treatment of men who may not be at risk.

14 Jun 2016

PI3K/AKT/mTOR pathway plays key role in prostate tumor growth and progression

The research article - Targeting the PI3K/AKT/mTOR Pathway in Prostate Cancer Development and Progression: Insight to Therapy, by Dr Claudio Festuccia and published in Clinical Cancer Drugs, volume 3, issue 1 - discusses experimental and clinical data on the pharmacological inhibition of the Akt/mTOR pathways.

13 Jun 2016

MRI-guided focal laser ablation could be feasible, safe in prostate cancer patients

Prostate cancer patients may soon have a new option to treat their disease: laser heat. UCLA researchers have found that focal laser ablation - the precise application of heat via laser to a tumor - is both feasible and safe in men with intermediate risk prostate cancer.

10 Jun 2016

Novel methods may help assess multipotent or unipotent fate of mammary gland, prostate stem cells

Stem cells ensure the development of tissues, their daily maintenance and their repair following injuries. One of the key questions in the field of stem cell biology is to define the different cell lineages in which stem cells can differentiate into.

9 Jun 2016

UAB receives new image-guided robotic system for early prostate cancer diagnosis

The world-renowned iSR'obotTM Mona Lisa makes its way to the United States, providing urologic surgeons with a tool to diagnose prostate cancer earlier through accurate diagnosis and precise localization that may allow for targeted treatments in the future.

9 Jun 2016

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

A recent pilot study reported in the June issue of The Journal of Nuclear Medicine found that sodium fluoride (Na-F-18) positron emission tomography/computed tomography (NaF-PET/CT) accurately detects bone metastases in patients with advanced prostate cancer, and follow-up scans over time correlate clearly with clinical outcomes and patient survival.

8 Jun 2016

Scientists discover unexpected functions of snoRNAs that explains cause of some diseases

Scientists have discovered unexpected functions of small nucleolar RNAs (snoRNAs) that explain the cause of some diseases.

7 Jun 2016

New clinical study data could redefine treatment for mCRPC patients

Janssen-Cilag International NV today announced that data from an interim analysis of The Prostate Cancer Registry, Europe’s first and largest prospective study of men with metastatic castration-resistant prostate cancer (mCRPC), indicate that the presence of distant metastases (M1) at initial diagnosis may be a critical indicator of future treatment and prognosis for mCRPC patients.

7 Jun 2016

Study shows aggressive end-of-life care for young cancer patients may be less effective

In the last month of their lives, younger cancer patients continued to be hospitalized and receive other aggressive treatment at high rates, a University of North Carolina Lineberger Comprehensive Cancer Center-led study found.

7 Jun 2016

Researchers find increased cancer incidence among patients with primary immunodeficiency disorders

Primary immunodeficiency disorders are a group of more than 300 single gene defects that affect the role of the immune system and prevent it from functioning properly. When Roswell Park Cancer Institute researchers evaluated the overall and site-specific incidence of cancer among patients registered in the United States Immune Deficiency Network, they found increased cancer incidence rates among patients with primary immunodeficiency diseases — and, in particular, a significant increase in lymphoma cases.

7 Jun 2016

Higher BMI and waist circumference may lead to increased risk of high grade prostate cancer

A study of almost 150,000 men from 8 European countries, presented at this year's European Obesity Summit shows that higher body mass index (BMI) and waist circumference are associated with an increased risk of aggressive prostate cancer.

3 Jun 2016

RSI-MRI imaging technology can effectively differentiate aggressive prostate cancer

Physicians have long used magnetic resonance imaging (MRI) to detect cancer but results of a University of California San Diego School of Medicine study describe the potential use of restriction spectrum imaging (RSI) as an imaging biomarker that enhances the ability of MRI to differentiate aggressive prostate cancer from low-grade or benign tumors and guide treatment and biopsy.

2 Jun 2016

Clinical trial to evaluate ability of MRI to improve prostate cancer diagnosis

The Movember Foundation, the Ontario Institute for Cancer Research and Prostate Cancer Canada today announced $3 million in funding for a new Phase III clinical trial to evaluate if magnetic resonance imaging (MRI) can replace the current standard of care to diagnose prostate cancer.

2 Jun 2016

Readmission rates after major cancer procedures depend on patient cohort, hospital characteristics

Readmission rates after complex cancer operations tend to be higher in hospitals that are considered to be vulnerable because they serve as safety nets in their communities or have a high number of Medicaid patients.

1 Jun 2016

Counsyl expands into oncology market to increase cancer risk screening

Counsyl, a DNA testing and genetic counseling service, today announced its expansion into the oncology market, with a focus on advancing cancer risk screening and helping cancer prevention efforts.

31 May 2016

Prostate News and Research

Scientists identify on/off obesity-induced switch to slow cancer progression

Fetal BPA exposure leads to harmful change in adult uterine response to estrogens

Nut consumption may lower risk of overall mortality in prostate cancer patients

MUTAs and GTAs act as medical model to train students

Prkci gene plays role in organizing cells during early embryo, organ formation

Screening PSA levels in younger men could accurately predict future risk of prostate cancer

PI3K/AKT/mTOR pathway plays key role in prostate tumor growth and progression

MRI-guided focal laser ablation could be feasible, safe in prostate cancer patients

Novel methods may help assess multipotent or unipotent fate of mammary gland, prostate stem cells

UAB receives new image-guided robotic system for early prostate cancer diagnosis

NaF-PET/CT scans can accurately detect bone metastases in advanced prostate cancer patients

Scientists discover unexpected functions of snoRNAs that explains cause of some diseases

New clinical study data could redefine treatment for mCRPC patients

Study shows aggressive end-of-life care for young cancer patients may be less effective

Researchers find increased cancer incidence among patients with primary immunodeficiency disorders

Higher BMI and waist circumference may lead to increased risk of high grade prostate cancer

RSI-MRI imaging technology can effectively differentiate aggressive prostate cancer

Clinical trial to evaluate ability of MRI to improve prostate cancer diagnosis

Readmission rates after major cancer procedures depend on patient cohort, hospital characteristics

Counsyl expands into oncology market to increase cancer risk screening

What to know about prostate cancer eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News